Clinical updates, including trial initiations, enrollment status and data readouts and publications: Agenus, Agios, Allysta, Astrazeneca, Athira, Axsome, Beigene, Bellerophon, Celularity, Codagenix, Dr. Reddy's, Galapagos, Genprex, Histogen, Ionis, Junshi, Neurotherapia, Nordic, Phathom, Plus, Rafael, Regenxbio, Russian Direct Investment Fund, Therapeutics Solution, Travere, Vyne, Zymeworks.